HYPR
HYPR
NASDAQ · Health Care

Hyperfine Inc

$0.84
+0.02 (+2.78%)
Financial Highlights (FY 2026)
Revenue
17.21M
Net Income
-45,133,852
Gross Margin
49.8%
Profit Margin
-262.3%
Rev Growth
+25.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 49.8% 49.8% 54.0% 54.0%
Operating Margin -273.4% -246.1% 7.3% 7.8%
Profit Margin -262.3% -249.2% 6.4% 7.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 17.21M 13.68M 58.96M 65.99M
Gross Profit 8.57M 6.81M 31.85M 35.64M
Operating Income -47,048,271 -33,662,011 4.29M 5.16M
Net Income -45,133,852 -32,292,286 3.76M 4.76M
Gross Margin 49.8% 49.8% 54.0% 54.0%
Operating Margin -273.4% -246.1% 7.3% 7.8%
Profit Margin -262.3% -249.2% 6.4% 7.2%
Rev Growth +25.8% +25.8% +13.9% +10.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 17.23M 13.59M
Total Equity — — 69.24M 70.24M
D/E Ratio — — 0.25 0.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -45,673,507 -34,493,864 6.38M 7.19M
Free Cash Flow — — 3.55M 3.68M